About Cameron Durrant
Cameron Durrant is a director at Neela Therapeutics.
Form D filings also name Cameron Durrant as a director at Alcyone Therapeutics.
Cameron Durrant first appears on SEC filings in 2013.
Experience
This experience comes from SEC filings. The years are when the filings name Cameron Durrant in the role, so the role may have started earlier or lasted longer.
Neela Therapeutics, Inc.
Director
2025 · Lunenburg, MA
Develops precision therapies for children with rare and serious diseases.
Key Colleagues at Startups
The people Cameron Durrant works with at each company, as listed on that company's latest Form D.
Neela Therapeutics, Inc. · Form D, Nov 24, 2025
DD
David Donabedian
Founding CEO, Newleos Therapeutics and director
SO
Stephen Oesterle
Director
RU
Richard Upton
Partner, Harbor Light Capital Partners and director
EJ
Edgar Jannotta Jr.
Board Observer
PA
Pj Anand
Founder, President and Chief Executive Officer, director
NR
Norbert Riedel
Chairman of the Board
Alcyone Therapeutics, Inc. · Form D/A, Jan 8, 2025
EJ
Edgar Jannotta
Director
DD
David Donabedian
Director
NR
Norbert Riedel
Director
SO
Stephen Oesterle
Director
PA
Pj Anand
Chief Executive Officer and director
RU
Richard Upton
Director